$7MSeries A, 2 March 2026
Oversubscribed round to speed clinical validation and deployment of its biosensing platform.
- Amount
- $7M
- Stage
- Series A
- Announced
- 2 March 2026
- Lead
- WI Harper
- Other investors
- Privilege Ventures, European Innovation Council
- Use of funds
- Oversubscribed round to speed clinical validation and deployment of its biosensing platform.
- Checked
- Announced by the company
- Sources
- Xsensio raises $7M oversubscribed Series A for wearable biosensing biospace.com
Xsensio raises $7M oversubscribed Series A for wearable biosensing prnewswire.com